Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641120 · ClinicalTrials.gov registry record · NA
Assessing Tolerability of Avonex Intramuscular Injections
A NA study, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01641120: Completed NA study, sponsored by Trinity Health Of New England.
NCT01641120 is a NA study that has completed, run by Trinity Health Of New England. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01641120, a NA study, has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
Primary Outcome
The primary endpoint of the study was a change in patient self-reported 100 mm (10 cm) Visual Analogue Scale (VAS) score for pre-injection anxiety. VAS scale (min=0- max=100 mm (10cm)) 0= no anxiety; 100 mm (10 cm)=very severe anxiety. Data from Weeks 2 and 3 were combined and averaged to obtain a single value as both weeks a 30 gauge needle was used for injection. The 30 gauge needle VAS mean refers to the mean for pre-injection anxiety for that needle size. Data from Weeks 4 and 5 were combi
Interventions
- DRUG Avonex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT01641120 record still lists
NCT01641120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Avonex is the first listed.
NCT01641120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01641120 about?
NCT01641120 is a clinical study titled "Assessing Tolerability of Avonex Intramuscular Injections". The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
What is the current status of trial NCT01641120?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01641120?
The interventions under investigation include: Avonex (DRUG).
Who is sponsoring clinical trial NCT01641120?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01641120's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia